ChitogenX’s name change was approved in July, and the company will appear on market tickers under a new symbol Sept. 12, according to a news release.
“We evaluated our Company name in light of the vast potential clinical and commercial applications for our proprietary technology platform, and it was obvious that these applications were much broader than just the orthopedic field the previous corporate name was inferring to,” CEO Philippe Deschamps said in the release. “We opted for a new company name that better represented our identity and expanded possibilities.”
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
